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Many  studies  have  reported  high  prevalence  of  hypogonadism  amongst  the  diabetic
patients  suggesting  the therapeutic  beneﬁts  of  testosterone  hormone  administration  to
these patients.  The  present  research  was  carried  out  to study  the  possible  role  of insulin,
testosterone  and  combined  insulin  and  testosterone  therapy  on  the  diabetic  rat  ventral
prostate.  Fifty-eight  adult  male  albino  rats  were  used  and  divided  into  2  main  groups;  the
control  and  the experimentally  induced  diabetic  group  that given  a single  intra-peritoneal
injection  of  STZ (60 mg/kg).  The  rats  with  conﬁrmed  DM  were  subdivided  into:  diabetic
group  that  kept  without  treatment,  diabetic–testosterone  group  (100  mg/kg/4  weeks,  S.C.),
diabetic–insulin  group  (5 IU/day/rat,  S.C.)  and  diabetic–insulin–testosterone  group.  After
8 weeks,  the  ventral  prostatic  lobes  were  dissected  and  processed  for parafﬁn  blocks  to
study the epithelial  height,  mast  cell  number,  expression  of  AR,  PCNA  and  active  caspase-3.
DM induced  a signiﬁcant  decrease  in  mast  cells  number,  epithelial  height  and  androgen
receptors  (AR)  with  a signiﬁcant  increase  in  the  apoptotic  index.  On  the  other hand,  the
epithelial  cells  showed  a  non-signiﬁcant  change  in  the proliferation  rate  compared  to  the
control  group.  Treatment  with  testosterone  induced  a  signiﬁcant  increase  in  the  epithelial
height,  number  of mast  cells  & AR  positive  epithelial  cells  and a non-signiﬁcant  increase  in
PCNA with  a signiﬁcant  decrease  in  the  active  caspase-3.  Treatment  with  insulin  showed
abundant  mast  cells  in the  stroma  with  a  signiﬁcant  increase  in epithelial  height  &  AR with
decrease  in  active  caspase-3  positive  cells  and  insigniﬁcant  changes  in  PCNA.  Combined
treatment  with  both  hormones  produced  similar  outcomes  to the  group  treated  with insulin
alone. It  was  concluded  that  diabetes  leads  to alterations  in  rat ventral  prostate  gland.  Early
insulin  treatment  attenuates  these  effects  with  preserving  most  of the  measured  param-
eters within  the normal  values.  Furthermore,  addition  of  testosterone  to insulin  did  not
seem to produce  a signiﬁcant  therapeutic  add.
di  Socie© 2014  Sau
. IntroductionDiabetes mellitus (DM) is a worldwide common dis-
ase. Its prevalence has been increased dramatically in
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recent years. Several investigators have conveyed the com-
plications  of DM on the structure and functions of the
sexual and reproductive organs. Impotency, reduced libido,
impairment of spermatogenesis, reduced sperm count and
motility,  decreased seminal ﬂuid volume and decrease
serum testosterone have been reported in diabetic men and
in  experimental animals [1]. The prostate gland depends
on  different hormones such as androgens, estrogens and
prolactin. The testosterone is the main androgen that is
ghts reserved.
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very important for the development of prostate and main-
tenance of its structural and functional integrity. The subtle
change  in the testosterone level is usually accompanied
by alteration in the growth and weight of the prostate
[2]. The rat prostate contains a signiﬁcant number of mast
cells,  with their density being higher during the pubertal
period and declining signiﬁcantly with age [3]. In the nor-
mal  prostate, androgens act through a paracrine process
with  different effects on different types of cells. Binding of
androgen  receptor by its ligand results in dimerization and
binding  of the receptor to regulatory sequences of speciﬁc
genes  in the nuclei of epithelial and stromal cells [4]. This
work  was performed to study the effect of streptozotocin-
induced diabetes on the prostate gland in adult rats and
to  study the role of insulin alone, testosterone alone and
their  combination in ameliorating the diabetic effect on the
prostate.
2.  Materials and methods
Fifty-eight  adult male albino rats weighing 226–255 g
each  were used. They were kept in clean ventilated cages
and  fed on a commercial diet at the animal research house
of  Strathclyde University, UK under a controlled environ-
ment. They were divided into the following groups: A –
The  control group (C): included 16 rats that were subdi-
vided into 2 equal subgroups: the ﬁrst was kept without
treatment, the second received a single intraperitoneal
(i.p.) injection of 0.2 ml  of 0.1 M sodium citrate. B – The
streptozotocin induced diabetic group: included 42 rats that
were  subjected to a single i.p. injection of 60 mg/kg strep-
tozotocin (STZ) dissolved in sodium citrate just before
injection [5]. Three days after STZ injection, the blood glu-
cose  levels were estimated using a blood glucose meter
(Accu-Check Advantage, Roche, Germany). Only rats with
blood  glucose level of (≥250 mg/dl) were considered dia-
betic  [6]. In this study, only 32 rats were proven to have
DM,  they were divided into 4 subgroups (8 rats each):
1  – The diabetic group (D): that received no additional
treatment. 2 – The diabetic–testosterone group (D ± T): that
received testosterone undecanoate 100 mg/kg b.w./day,
S.C.  [7]. 3 – The diabetic–insulin group (D ± I): that received
human insulin (Humulin I), 5 IU/rat/day, S.C. [6]. 4 – The
diabetic–insulin–testosterone group (D ± I ± T): that received
insulin plus testosterone simultaneously as described
above.
After 8 weeks, the animals were anaesthetized by
intraperitoneal injection of sodium pentobarbital in a dose
of  30 mg/kg b.w. [8]. The ventral lobes of the prostate
gland of all animals were dissected and their middle areas
were  taken and processed for parafﬁn sections which were
stained  by toluidine blue for study of mast cell number
and epithelial height and used also for immunohistochem-
ical study of androgen receptor, caspase-3 and proliferative
nuclear antigen (PCNA).
2.1.  ImmunohistochemistryThe sections were collected on APES coated slides,
heat-mediated antigen retrieval was performed in pres-
sure  cooker with 0.1 M sodium citrate buffer (pH 6.0). Thed Ultrastructure 2 (2014) 151–160
endogenous peroxidase was inactivated by 3% H2O2 in
methanol for 30 min. The sections were treated with bovine
serum  albumin and normal goat serum in TBS as a blocking
buffer for 1 h at RT then incubated overnight in a humid-
ity  chamber at 4 ◦C with primary antibodies (Polyclonal
rabbit anti-Active caspase-3/ab1:300) and (Rabbit anti-
Androgen receptor 1:100). On the next day, the sections
were rinsed in 1% TBS–Tween-20 and TBS and incubated for
1  h at RT with the secondary antibodies (biotinylated goat
anti-mouse and anti-rabbit/1:200). Avidin–biotin-complex
reagent was  added followed by incubating the sections
with 3,3-diaminobenzidine (DAB) as a chromogen with
Mayer’s hematoxylin as a counter-stain then mounted with
DPX.  Negative control sections were obtained by removing
the  primary antibody and replaced by blocking solution [9].
2.2.  Immunoﬂuorescence study
Monoclonal mouse anti-PCNA (1:1000) as well as sec-
ondary antibody (Alexa Fluor 488 goat anti-mouse IgG)
were  used followed by vectashield mounting medium with
DAPI  (diamidino-2-phenylindole) [9] then examined and
photographed by a ﬂuorescent microscope.
2.3. Morphometric studies
The  epithelial height was  measured by a straight line
extending from the basement membrane to the top of the
tall  epithelial lining of the middle area of the ventral gland
described as a percentage of the control values and the
mast  cell number was  quantiﬁed by counting the number
of  toluidine blue positive cells, both at ×400 ﬁeld magniﬁ-
cation using 15 random ﬁelds from 5 different rats in each
group  using image J software. AR, PCNA, and active caspase-
3  were expressed as a percentage of total cell count (the
number of positive epithelial cells × 100/total number of
epithelial cells) by using 10 random ﬁelds from 5 differ-
ent  rats in each group using image J software at ×400 for
AR,  active caspase-3 and at ×200 for PCNA). All of these
parameters were done at Histology Department, Faculty of
Medicine,  Tanta University.
2.4.  Statistical analysis
All  the values were expressed as the mean ± standard
error of mean. Data was statistically analyzed using one-
way  ANOVA followed by Tukey’s post-test. p-Value ≤0.05
was  considered statistically signiﬁcant. All statistical anal-
yses  were performed using Prism 5 software.
3. Results
Two  rats were found dead after 6 weeks of treatment,
one rat from the (D + I) group and the other from (D + I + T)
group.
3.1.  Light microscopic and morphometric resultsExamination of parafﬁn sections stained with tolui-
dine blue which is speciﬁc for mast cells revealed in the
control group (C), many mast cells with metachromatic
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D  + T) and combined hormonal treatment (D + T + I) showing many mast 
roups.  L: lumena; S: stroma; BV: blood vessels (toluidine blue ×400).
ranules stained violet/red purple. These mast cells were
ocalized in the stroma between the prostatic acini often
lose  to the blood vessels. The diabetic group (D), showed
pparent few mast cells in comparison to the control and
he  diabetic–testosterone group (D + T), showed appar-
nt  increase in the number of mast cells with apparent
pithelial hyperplasia. Furthermore, there are abundant
ast cells in the stroma of the sections obtained from the
iabetic–insulin group (D + I), that appeared scattered or
n  groups. The diabetic rats received combined hormonal
reatment (D + T + I), showed many mast cells of variable
izes in the stroma between the acini (Fig. 1).Morphometrically: there was a signiﬁcant decrease in
he  epithelial height lining the prostatic acini of the
ntreated diabetic group compared to that of the control
roup. While the epithelial height of the diabetic groupsd few mast cells in the diabetic group (D). While, testosterone treatment
ulin (D + I) treatment showing abundant mast cells scattered singly or in
treated  with testosterone, insulin and testosterone plus
insulin  displayed signiﬁcant higher values compared to
that  of the untreated diabetic group (Table 1 and Fig. 2,
Histogram A). The mast cell number in the ventral prostate
conﬁrmed the microscopic results and revealed a signiﬁ-
cant  decrease in the number of mast cells in diabetic rats
in  comparison with that of the control rats. On the other
hand,  there was a signiﬁcant increase in the number of
mast  cells with testosterone treatment compared to that
of  untreated diabetic group. While diabetic–insulin group
showed a signiﬁcant increase in the mast cells compared
to all other groups (the diabetic, the diabetic–testosterone
and the control groups). There was a signiﬁcant increase in
mast  cell’s number in diabetic rats treated with insulin plus
testosterone in comparison with that of the diabetic group
(Table  1 and Fig. 2, Histogram B).
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Table 1
The  average values of the epithelial height, mast cell number/ﬁeld, AR, PCNA and active caspase-3 of the experimental groups.
Groups Epithelial height Mast cell AR Active-caspase-3 PCNA
C 100 ± 3.3 4.4 ± 0.52 78.09 ± 1.8 0.4785 ± 0.1112 8.391 ± 0.8
D  63.88 ± 2.6*** 2.04 ± 0.25*** 50.81 ± 2.5*** 2.407 ± 0.5796*** 6.871 ± 0.8
D  + T 99.13 ± 3.9*** 6.0 ± 0.44*** 96.29 ± 0.9*** 1.400 ± 0.2142*** 9.830 ± 1.8
D  + I 95.97 ± 4.7*** 8.13 ± 1*** 76.43 ± 4.4*** 0.5374 ± 0.1293*** 7.365 ± 1.0
D  + I + T 85.46  ± 2.4*** 6.6 ± 0.84*** 86.09 ± 3.5*** 0.6859 ± 0.1162*** 8.1 ± 1.034
*** p < 0.0001.
Fig. 2. Histogram A showing measurement of epithelial heights of rat ventral prostate of the experimental groups: (C) control; (D) untreated diabetic;
(D  + T) diabetic treated with testosterone; (D + I) diabetic treated with insulin; (D + I + T) diabetic treated with insulin plus testosterone. Histogram B shows
 the and
ive cell n
ences.quantiﬁcation  of mast cells. Histograms C, D and E show quantiﬁcation of
positive  epithelial cells (apoptotic index) and quantiﬁcation of proliferat
in  all the experimental groups. Different letters indicate signiﬁcant differ
3.2. Immunohistochemical resultsAndrogen receptor (AR): speciﬁcity of antibody reaction
was conﬁrmed by the absence of staining either in the
nuclei or the cytoplasm of the negative control. The con-
trol  group showed a positive immunoreactivity which wasrogen receptor positive epithelial cells, quantiﬁcation of active caspase-3
uclear antigen positive epithelial cells (proliferative index) respectively
labeled  as a brown color in the nuclei of the epithelial
and stromal cells of the prostatic acini. However, the
immunostaining of AR was  apparently more intense in the
epithelial  cells than stromal cells. The untreated diabetic
group showed apparent decrease in the number of the
positive epithelial cell nuclei compared to control group.
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Fig. 3. Negative control (N) for AR immunostaining showing no immunoreaction in the cytoplasm or nucleus either in the glandular epithelial cells or
stromal  cells. Control group (C) shows many positive nuclear immunoreaction (arrows) for AR in the glandular epithelial cells and few immunoreactions
in  the stromal cells (arrow heads). Diabetic group (D) shows apparent decrease in number of positive immunoreaction (arrows) in the epithelial cells with
some  positive stromal cells (arrow heads). Testosterone treated group (D + T) shows positive nuclear immunoreaction (arrows) nearly in all epithelial cells
with some positive stromal cells (arrow heads). Insulin treated group (D + I) shows many positive immunoreaction (arrows) in epithelial cells with some
positive  immunoreaction (arrow heads) in the stromal cells. Combined hormonal treatment (D + T + I) shows positive nuclear immunoreaction (arrows) in
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tost  of the epithelial cells. L: lumena; S: stroma; BV: blood vessels (AR im
he diabetic rats treated with testosterone showed appar-
nt  increase in the number of AR positive epithelial cells,
lmost  all nuclei of the epithelial cells showed a positive
mmunoreaction of the AR. The treatment with insulin also
howed  apparent increase in the number of positive nuclei
han  that of diabetic group but less than those treated
ith testosterone. Furthermore, the combined hormonal
herapy with insulin plus testosterone showed apparent
ncrease in the AR immunopositive nuclei in the epithelial
ells  compared to the untreated diabetic rats (Fig. 3).
The  statistical results showed a signiﬁcant decrease in
he  percentage of AR positive epithelial cells in the diabetictaining ×400).
group  compared to the control group. There was  a sig-
niﬁcant increase in the percentage of AR positive cells in
the  diabetic animals treated with testosterone, insulin and
combined  insulin plus testosterone in comparison to that
of  the untreated diabetic rats. In addition, diabetic–insulin
group showed a signiﬁcant decrease in the percent-
age of AR positive epithelial cells compared to the
diabetic–testosterone group but no signiﬁcant differences
were reported in the percentage of the AR immunoreaction
in combined hormonal-treatment group compared to the
insulin  treated diabetic group (Table 1 and Fig. 2, Histogram
C).
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Fig. 4. Showing localized positive cytoplasmic immunoreactions (arrows) in the glandular epithelial cells in control group (C), accumulation of many
positive  cells (arrow head) in the lumen of the acini in diabetic group (D), localized positive nuclear immunoreaction (arrows) in some nuclei surrounded by
 (D + T), l
 + T + I) dvacuolated  cytoplasm (arrow heads) in testosterone treated diabetic rats
epithelium  in insulin treated (D + I) and combined hormonal treated (D
immunostaining ×400).
3.3. Active caspase-3 (an apoptotic marker)
Immunohistochemical staining of the sections obtained
from the control group showed a little active caspase-3
immunoreactivity in the cytoplasm of glandular epithelial
cells.  The diabetic group showed increased number of
positive  epithelial cells compared to control group. The
anti-active caspase-3 was localized in the cytoplasm as
well  as in the nuclei of cells. The majority of the reactions
were noted in the epithelial cells during process of sep-
aration from the acini and in the already separated cells
in  the lumen. There was apparent decrease in the expres-
sion  of the active caspase-3 in the diabetic–testosterone
group. Furthermore, the diabetic–insulin group and that
with  combined hormonal treatment showed a few positiveocalized positive cytoplasmic immunoreaction (arrows) in the glandular
iabetic rats. L: lumena; S: stroma; BV: blood vessels (active caspase-3
cytoplasmic immunostaining of active caspase-3 in the
epithelial cells (Fig. 4).
Expression  of the active caspase-3 in the epithelial
cells of the ventral prostate was quantiﬁed as an apop-
totic index. It was  calculated by dividing the number of
epithelial cells with positive reaction of active caspase-
3  by the total number of the epithelial cells. Our results
showed a highly signiﬁcant increase in the apoptotic index
in  the diabetic group compared to the control group. On
the  other hand, the diabetic–testosterone group showed
a  signiﬁcantly lower average value of apoptotic index
than those found in the diabetic group. However, it was
signiﬁcantly higher than that of the control group. The
diabetic–insulin group showed a signiﬁcant low average
value of the index compared to the diabetic group and it
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Fig. 5. Showing nuclear localization of PCNA immunostaining in the nuclei of some glandular epithelial cells (green arrow) and positive nuclear immuno-
staining  (blue color) for DAPI in the glandular epithelial cells in control (C), diabetic (D), testosterone treated (D + T), insulin treated (D + I) and combined
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as insigniﬁcant compared to the control group. Whereas
he  diabetic–insulin–testosterone group showed a highly
igniﬁcant decrease in the index compared to the diabetic
roup, with no signiﬁcant difference compared to other
xperimental groups (Table 1 and Fig. 2, Histogram D).
.4.  Immunoﬂuorescent study of proliferating cell
uclear antigen (PCNA)
The  merge images of both DAPI and PCNA immunore-
ction of the same section conﬁrmed the co-localization
f PCNA positive immunoreaction and the DAPI staining
enoting nuclear localization of the PCNA in the glandular
pithelium of all experimental groups. The immunostain-
ng for PCNA in the control group showed positive nuclear
eaction in some acinar epithelial cells. This reaction.
appeared as a green coloration of the nuclei of the positive
cells. The diabetic group showed apparently few posi-
tive  nuclear immunoreaction in glandular epithelial cells
(secretory tall columnar cells) with positive immunore-
action in the stromal cells. The diabetic group treated
with testosterone, displayed the same pattern of nuclear
immunostaining for PCNA in the glandular epithelium with
apparent  increase in the positive nuclei compared to the
control  and the diabetic groups. However, the diabetic
rats that were treated with insulin alone or combined
hormones showed few positive nuclei for PCNA in the glan-
dular  epithelium (secretory tall columnar cells) (Fig. 5). The
quantitative analysis of PCNA-labeling index in the glan-
dular  epithelium showed no signiﬁcant variation in the
proliferative activity between the different experimental
groups (Table 1 and Fig. 2, Histogram E).
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4. Discussion
Many studies have shown that between 20% and 64% of
diabetic  men  are suffering from hypogonadism, with high
prevalence in the elderly that can be related to decreased
sex hormone binding globulin, decreased gonadotrophin
release or testosterone production. On the other hand,
hypogonadism could be a contributing factor to diabetes
due  to the changes in the body composition, androgen
receptor polymorphisms, glucose transport and reduced
level  of the antioxidants [10].
In this study, there was marked epithelial atrophy in the
glandular epithelium of diabetic group that was in agree-
ment  with a previous work [11] which showed a reduction
in  the glandular epithelial height and the volume of the
epithelium in experimental diabetes. The prostatic atrophy
in  diabetes is similar to the prostatic involution follow-
ing  castration, which is due to the selective loss of the
androgen-dependent secretory epithelial cells due to apo-
ptosis  and is accompanied by a marked reduction of both
the  cytoplasmic and nuclear androgen receptor content.
These changes can be prevented by the administration of
androgens [12] that reﬂect the anabolic effect of testos-
terone and its role in cell proliferation and stromal growth
[13].  The growth-promoting effects of insulin may  be due
to  its role in stimulating the production of testosterone
by affecting the hypothalamic–hypophyseal–testes axis as
well  as its local effects through insulin receptors [14].
In  addition, some stated that blocking insulin production
during sexual maturation compromises prostate growth
[15].
Some  workers [16] had reported that prostatic mast cell
degranulation and histamine release may  induce smooth
muscle contraction in the prostate. This ﬁnding may  clar-
ify  the accumulation of the mast cells in the stoma near
the  smooth muscle and the glandular epithelium. Mast
cells  are often observed in close relation to the blood
vessels that justiﬁes the involvement of mast cells in
the  angiogenesis and the vascular control of the prostate
[17]. The present work showed a signiﬁcant decrease
in the number of mast cells in diabetic group, this was
observed previously by reporting a severe reduction in
number  of the mast cell in different body sites such
as mesentery and intestine under the diabetic condition
[18]. Others [19] reported also a decrease in the num-
ber  of pleural mast cells in alloxan-induced diabetes. The
diabetes  is associated with an increase in the serum glu-
cocorticoid which plays a role in the depletion of mast
cells  from different body sites as skin, lung and intestine
[20].
In  this study, treatment with testosterone, insulin
or combined hormonal therapy was associated with an
increase  in the number of the mast cells. Some authors
[21] observed that surgical adrenalectomy and treatment
with steroid receptor antagonist completely reversed the
mast  cell depletion observed under the diabetic condi-
tions. Others reported accumulation of the mast cells in the
rat  prostate during the ﬁrst day of testosterone treatment
[22]. Some investigators reported an increase in the pleu-
ral  mast cells of diabetic rats after insulin treatment [23].
Similar  ﬁndings showed that insulin might modulate mastd Ultrastructure 2 (2014) 151–160
cell  degranulation at the early-phase response to antigen
provocation decreasing the risk of asthma among type-1
diabetic patients. This also could be attributed to the mod-
iﬁcation in the level of corticosteroids [24].
The distribution of AR varied in the different cells of rat
ventral prostate, the nuclear staining for AR in the epithe-
lial  cells was stronger than that of the stromal cells and
these  verities in the expression of AR in different types of
cells  of rat ventral prostate suggest that these cells have
different AR contents and different responses to andro-
gen  [25]. In this study, there was a signiﬁcant decrease
in the androgen receptor expression in the diabetic rats.
This  ﬁnding was in line with other studies that stated that
the  intensity of AR reaction was lower one week after
diabetes when compared to respective controls and they
related  that to the lower testosterone level in diabetic state
[6].  In the same time, they also stated that three months
after alloxan-induced diabetes, there was  no changes in
the  frequency of AR-positive cells in the prostatic acinar
epithelium compared to their age matched control group
and  related that to the already low level of testosterone
in older rats. It was  stated that the expression of AR mRNA
decreases in testis, epididymis and prostate of diabetic rats,
that  weakening the biological effects of AR and it might be
one  of the causes responsible for the sexual and reproduc-
tive dysfunction in the diabetic rats [26]. In this study, the
diabetic  rats received treatment with insulin and testos-
terone showed signiﬁcant increase in the AR expression,
these observations were in line with the ability of com-
bined insulin and testosterone to restore the weight of
the  accessory sex gland with partial structural recovery
[27].
However, in this study, there was  a positive immu-
nostaining for active caspase-3 in the control rats that
was  supported by some authors who revealed the pos-
itive  active caspase-3 immunoreaction in the epithelial
cells of prostatic acini from the control rats [28]. The
quantitative analysis of apoptotic index showed that the
apoptotic cells were more abundant in diabetic rats espe-
cially  in detached epithelial cells in the acinar lumen. Some
researchers conﬁrmed that diabetes stimulates apoptosis
in  different organs including the prostate [29]. Addition-
ally, it has been reported that the apoptotic rate in the
ventral prostate of the diabetic group increased with the
disease  progression which suggests that these alterations
might be due to low testosterone level that reported in
diabetes as a potential cause for the increased apopto-
sis in the diabetic tissues [30]. As well as the increase
in the oxidative stress condition with the reduction in
the  level of the antioxidant enzymes in diabetes directly
induce apoptosis by damaging the DNA [31]. The anti-
apoptotic role of testosterone may  contribute to the ability
of  testosterone to up regulate the expression of anti-
apoptotic genes such as bcl-2 [32]. It was  reported that
insulin administration reduced the overall rate of apopto-
sis  in the presence and absence of androgen stimulation
[11].Proliferating cell nuclear antigen (PCNA) expression
usually used to discriminate cycling from non-cycling cells
and  is localized to the nuclei of the proliferating cells [33].
In  this study, the results revealed no signiﬁcant variations
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fter  8 weeks in the diabetic state. These ﬁndings were also
bserved  after one week in the diabetic state as there was a
otably  low intensity of AR that resulted in the decrease in
he  growth factors (released from the stromal cells) with
onsequent impairment of the cellular proliferations [6].
hile,  others observed a marked reduction in the cell pro-
iferation  levels in the acinar epithelium of the ventral
rostate after one month of diabetes [28].
Furthermore, previous reports about testosterone
upplementation in diabetic animals revealed that the
ndrogen does not completely establish changes in
he  reproductive system, while insulin replacement can
everse  the prostatic involution and serum level of testos-
erone  [34]. In another recent study, administration of
nsulin,  testosterone and estrogen alone did not restore the
alance  between the proliferation and apoptosis in non-
bese  diabetic mice. While, the combined administration
f the three hormones produced morphological recovery
f  the prostate [35].
.  Conclusion
Early diagnosis of type I diabetic patients and treatment
ith the optimal type and dose of insulin are recom-
ended. Great precautions should be taken with long
cting testosterone with restriction of its application only
o  the cases suffering from clear hypogonadism associ-
ted with diabetes mellitus. Further studies are required
o  better understand the role of insulin and testosterone
n maintaining the morphology and the function of the
rostate gland and other reproductive organs.
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